Compound details
(-)-beta-Peltatin;beta-Peltatin
| Compound ID | CDAMM00512 |
|---|---|
| Common name | (-)-beta-Peltatin;beta-Peltatin | IUPAC name | 4-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one |
| Molecular formula | C22H22O8 |
| Retention time | 8.21 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 437.126 | Theoretical mz | 437.12 |
| Error | 12.54 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 8.6733 |
| Inchi key | HLBPOYVRLSXWJJ-XUGCUHNJNA-N |
|---|---|
| Smiles | O=C1OCC2CC3=C(O)C=4OCOC4C=C3C(C5=CC(OC)=C(OC)C(OC)=C5)C12 |
| Superclass | Lignans, neolignans and related compounds |
| Class | Lignan lactones |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| Q96KS0 | EIT6 | HIF-prolyl hydroxylase 1 | T53904 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P42338 | PIK3CB | PI3-kinase p110-beta subunit | T05031 | SwissTargetPrediction |
| P11712 | CYP2C9 | Cytochrome P450 2C9 | T19244 | SwissTargetPrediction |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | T37848 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P06239 | LCK | Tyrosine-protein kinase LCK | T12499 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| Q8IXJ6 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | T83904 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| Q96RJ0 | TAAR1 | Trace amine-associated receptor 1 (by homology) | T99524 | SwissTargetPrediction |
| P07949 | RET | Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET | T60631 | SwissTargetPrediction |
| Q01959 | SLC6A3 | Dopamine transporter | T55959 | SwissTargetPrediction |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction |
| P07384 | CAPN1 | Calpain 1 | T92517 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SwissTargetPrediction |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SwissTargetPrediction |
| Q7Z2W7 | TRPM8 | Transient receptor potential cation channel subfamily M member 8 | T41955 | SwissTargetPrediction |
| P14174 | MIF | Macrophage migration inhibitory factor | T39977 | SwissTargetPrediction |
| O00206 | TLR4 | Toll-like receptor 4 (by homology) | T81443 | SEA |
| P23975 | SLC6A2 | Norepinephrine transporter | T21945 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SEA |
| P54760 | EPHB4 | Ephrin receptor | T49507 | SwissTargetPrediction |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P00519 | ABL1 | Tyrosine-protein kinase ABL | T63505 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| Q16769 | QPCT | Glutaminyl-peptide cyclotransferase | T46245 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P00742 | F10 | Thrombin and coagulation factor X | T84631 | SwissTargetPrediction |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SwissTargetPrediction |
| O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | T01003 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | T96623 | SwissTargetPrediction |
| P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | T18477 | SwissTargetPrediction |
| P47871 | GCGR | Glucagon receptor | T60182 | SwissTargetPrediction |
| Q05397 | PTK2 | Focal adhesion kinase 1 | T15068 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | T99057 | SwissTargetPrediction |
| O00329 | PIK3CD | PI3-kinase p110-delta subunit | T67849 | SwissTargetPrediction |
| P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | T09538 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P29375 | KDM5A | Lysine-specific demethylase 5A | T28052 | SwissTargetPrediction |
| P40763 | STAT3 | Signal transducer and activator of transcription 3 | T29130 | SwissTargetPrediction |
| Q9Y463 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | T82720 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| Q96EB6 | SIRT1 | NAD-dependent deacetylase sirtuin 1 | T14731 | SwissTargetPrediction |
| Q14289 | PTK2B | Protein tyrosine kinase 2 beta | T07087 | SwissTargetPrediction |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SwissTargetPrediction |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SwissTargetPrediction and SEA |
| P23526 | AHCY | Adenosylhomocysteinase | T68698 | SwissTargetPrediction |
| P34998 | CRHR1 | Corticotropin releasing factor receptor 1 (by homology) | T45262 | SwissTargetPrediction |
| Q9Y5Z0 | BACE2 | Beta secretase 2 | T01280 | SwissTargetPrediction |
| Q02127 | DHODH | Dihydroorotate dehydrogenase | T61400 | SwissTargetPrediction |
| P48736 | PIK3CG | PI3-kinase p110-gamma subunit | T95913 | SwissTargetPrediction |
| O76074 | PDE5A | Phosphodiesterase 5A | T07663 | SwissTargetPrediction |
| P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | T40111 | SwissTargetPrediction |
| P78527 | PRKDC | DNA-dependent protein kinase | T81735 | SwissTargetPrediction |
| P04049 | RAF1 | Serine/threonine-protein kinase RAF | T51883 | SwissTargetPrediction |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | T99089 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SwissTargetPrediction |
| P51164 | ATP4B | Potassium-transporting ATPase | T92687 | SwissTargetPrediction |
| Q12791 | KCNMA1 | Calcium-activated potassium channel subunit alpha-1 | T66538 | SwissTargetPrediction |
| P08236 | GUSB | Beta-glucuronidase | T96413 | SwissTargetPrediction |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha 3 | T03279 | SwissTargetPrediction |
| Q9NPH5 | NOX4 | NADPH oxidase 4 | T29741 | SwissTargetPrediction |
| O00408 | PDE2A | Phosphodiesterase 2A | T77400 | SwissTargetPrediction |
| P19525 | EIF2AK2 | Interferon-induced, double-stranded RNA-activated protein kinase | T04831 | SwissTargetPrediction |
| P08631 | HCK | Tyrosine-protein kinase HCK | T31406 | SwissTargetPrediction |
| Q9UIQ6 | LNPEP | Cystinyl aminopeptidase | T97537 | SwissTargetPrediction |
| Q9HCP0 | CSNK1G1 | Casein kinase I gamma 1 | T41702 | SwissTargetPrediction |
| Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha 1 | T83202 | SwissTargetPrediction |
| Q9UBF8 | PI4KB | PI4-kinase beta subunit | T12541 | SwissTargetPrediction |
| P29323 | EPHB2 | Ephrin type-B receptor 2 | T73756 | SwissTargetPrediction |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SwissTargetPrediction |
| P29320 | EPHA3 | Ephrin type-A receptor 3 | T28413 | SwissTargetPrediction |
| P30281 | CCND3 | Cyclin-dependent kinase 4/cyclin D | T72507 | SwissTargetPrediction |
| Q9BUB5 | MKNK1 | MAP kinase-interacting serine/threonine-protein kinase MNK1 | T97136 | SwissTargetPrediction |
| P63316 | TNNC1 | Troponin, cardiac muscle | T12966 | SwissTargetPrediction |
| P37173 | TGFBR2 | TGF-beta receptor type II | T49989 | SwissTargetPrediction |
| P00740 | F9 | Coagulation factor IX | T83369 | SwissTargetPrediction |
| P51843 | NR0B1 | Orphan nuclear receptor DAX-1 | T23191 | SEA |
| Q02880 | TOP2B | DNA topoisomerase II beta | T85733 | SEA |
| H3BPQ1 | TCF4 | Transcription factor 7-like 2 | T54646 | SEA |
| Q9GZT9 | EGLN1 | Egl nine homolog 1 | T32880 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T53904 | DI0010 | Acute disease anaemia | [ICD-11: 3A90] | Q96KS0 | EIT6 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T05031 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42338 | PIK3CB |
| T19244 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11712 | CYP2C9 |
| T37848 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08684 | CYP3A4 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T12499 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06239 | LCK |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T83904 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q8IXJ6 | SIRT2 |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T99524 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q96RJ0 | TAAR1 |
| T99524 | DI0149 | Focal/segmental autonomic disorder | [ICD-11: 8D8A] | Q96RJ0 | TAAR1 |
| T99524 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q96RJ0 | TAAR1 |
| T60631 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P07949 | RET |
| T60631 | DI0238 | Lung cancer | [ICD-11: 2C25] | P07949 | RET |
| T60631 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P07949 | RET |
| T60631 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P07949 | RET |
| T60631 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P07949 | RET |
| T60631 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P07949 | RET |
| T55959 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q01959 | SLC6A3 |
| T55959 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q01959 | SLC6A3 |
| T55959 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q01959 | SLC6A3 |
| T55959 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q01959 | SLC6A3 |
| T55959 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q01959 | SLC6A3 |
| T55959 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q01959 | SLC6A3 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T41955 | DI0422 | Upper respiratory tract disorder | [ICD-11: CA0Z] | Q7Z2W7 | TRPM8 |
| T39977 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P14174 | MIF |
| T81443 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | O00206 | TLR4 |
| T81443 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O00206 | TLR4 |
| T81443 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | O00206 | TLR4 |
| T21945 | DI0013 | Acute pain | [ICD-11: MG31] | P23975 | SLC6A2 |
| T21945 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P23975 | SLC6A2 |
| T21945 | DI0087 | Chronic pain | [ICD-11: MG30] | P23975 | SLC6A2 |
| T21945 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P23975 | SLC6A2 |
| T21945 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P23975 | SLC6A2 |
| T21945 | DI0166 | Glaucoma | [ICD-11: 9C61] | P23975 | SLC6A2 |
| T21945 | DI0264 | Migraine | [ICD-11: 8A80] | P23975 | SLC6A2 |
| T21945 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P23975 | SLC6A2 |
| T21945 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P23975 | SLC6A2 |
| T21945 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P23975 | SLC6A2 |
| T21945 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P23975 | SLC6A2 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T49507 | DI0060 | Brain cancer | [ICD-11: 2A00] | P54760 | EPHB4 |
| T49507 | DI0111 | Cystic/dysplastic kidney disease | [ICD-11: GB8Y] | P54760 | EPHB4 |
| T49507 | DI0238 | Lung cancer | [ICD-11: 2C25] | P54760 | EPHB4 |
| T49507 | DI0261 | Metastatic meninges neoplasm | [ICD-11: 2D51] | P54760 | EPHB4 |
| T49507 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P54760 | EPHB4 |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T63505 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00519 | ABL1 |
| T63505 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00519 | ABL1 |
| T63505 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P00519 | ABL1 |
| T63505 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00519 | ABL1 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T46245 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | Q16769 | QPCT |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T84631 | DI0053 | Blood-forming organ disease | [ICD-11: 3C0Z] | P00742 | F10 |
| T84631 | DI0080 | Christmas disease | [ICD-11: 3B11] | P00742 | F10 |
| T84631 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00742 | F10 |
| T84631 | DI0103 | Coronary thrombosis | [ICD-11: BA43] | P00742 | F10 |
| T84631 | DI0114 | Deep vein thrombosis | [ICD-11: BD71] | P00742 | F10 |
| T84631 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P00742 | F10 |
| T84631 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P00742 | F10 |
| T84631 | DI0433 | Venous thromboembolism | [ICD-11: BD72] | P00742 | F10 |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T01003 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O75460 | ERN1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T96623 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P08238 | HSP90AB1 |
| T96623 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08238 | HSP90AB1 |
| T96623 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P08238 | HSP90AB1 |
| T96623 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P08238 | HSP90AB1 |
| T96623 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P08238 | HSP90AB1 |
| T96623 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08238 | HSP90AB1 |
| T96623 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P08238 | HSP90AB1 |
| T18477 | DI0015 | Acute upper respiratory infection | [ICD-11: CA07] | P07900 | HSP90AA1 |
| T18477 | DI0037 | Asthma | [ICD-11: CA23] | P07900 | HSP90AA1 |
| T60182 | DI0193 | Hypo-glycaemia | [ICD-11: 5A41] | P47871 | GCGR |
| T15068 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q05397 | PTK2 |
| T15068 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q05397 | PTK2 |
| T15068 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | Q05397 | PTK2 |
| T15068 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | Q05397 | PTK2 |
| T15068 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | Q05397 | PTK2 |
| T15068 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q05397 | PTK2 |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T99057 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q02750 | MAP2K1 |
| T99057 | DI0336 | Phakomatoses/hamartoneoplastic syndrome | [ICD-11: LD2D] | Q02750 | MAP2K1 |
| T67849 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | O00329 | PIK3CD |
| T67849 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00329 | PIK3CD |
| T67849 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | O00329 | PIK3CD |
| T67849 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | O00329 | PIK3CD |
| T67849 | DI0395 | Stomach cancer | [ICD-11: 2B72] | O00329 | PIK3CD |
| T09538 | DI0164 | Genetic prion disease | [ICD-11: 8E02] | P05186 | ALPL |
| T09538 | DI0330 | Parasitic infection | [ICD-11: 1D0Y-1G2Z] | P05186 | ALPL |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T29130 | DI0351 | Psoriasis | [ICD-11: EA90] | P40763 | STAT3 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T14731 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q96EB6 | SIRT1 |
| T14731 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q96EB6 | SIRT1 |
| T14731 | DI0431 | Vasculitis | [ICD-11: 4A44] | Q96EB6 | SIRT1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T45262 | DI0394 | Staphylococcal/streptococcal disease | [ICD-11: 1B5Y] | P34998 | CRHR1 |
| T01280 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | Q9Y5Z0 | BACE2 |
| T61400 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q02127 | DHODH |
| T61400 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | Q02127 | DHODH |
| T95913 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P48736 | PIK3CG |
| T95913 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P48736 | PIK3CG |
| T95913 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P48736 | PIK3CG |
| T07663 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O76074 | PDE5A |
| T07663 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | O76074 | PDE5A |
| T07663 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | O76074 | PDE5A |
| T07663 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | O76074 | PDE5A |
| T40111 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P20839 | IMPDH1 |
| T40111 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P20839 | IMPDH1 |
| T40111 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P20839 | IMPDH1 |
| T40111 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P20839 | IMPDH1 |
| T40111 | DI0413 | Transplant rejection | [ICD-11: NE84] | P20839 | IMPDH1 |
| T81735 | DI0360 | Rectum cancer | [ICD-11: 2B92] | P78527 | PRKDC |
| T81735 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P78527 | PRKDC |
| T51883 | DI0252 | Melanoma | [ICD-11: 2C30] | P04049 | RAF1 |
| T51883 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04049 | RAF1 |
| T51883 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P04049 | RAF1 |
| T51883 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04049 | RAF1 |
| T99089 | DI0252 | Melanoma | [ICD-11: 2C30] | P15056 | BRAF |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T92687 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | P51164 | ATP4B |
| T92687 | DI0176 | Helicobacter infection | [ICD-11: DA42-DA63] | P51164 | ATP4B |
| T92687 | DI0312 | Oesophageal ulcer | [ICD-11: DA25] | P51164 | ATP4B |
| T92687 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P51164 | ATP4B |
| T66538 | DI0037 | Asthma | [ICD-11: CA23] | Q12791 | KCNMA1 |
| T66538 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | Q12791 | KCNMA1 |
| T96413 | DI0242 | Lysosomal disease | [ICD-11: 5C56] | P08236 | GUSB |
| T03279 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P51812 | RPS6KA3 |
| T29741 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9NPH5 | NOX4 |
| T77400 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | O00408 | PDE2A |
| T77400 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | O00408 | PDE2A |
| T77400 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | O00408 | PDE2A |
| T77400 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | O00408 | PDE2A |
| T31406 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P08631 | HCK |
| T83202 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q15418 | RPS6KA1 |
| T12541 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | Q9UBF8 | PI4KB |
| T12541 | DI0440 | Zoonotic viral disease | ICD-11: 1D6Y | Q9UBF8 | PI4KB |
| T73756 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P29323 | EPHB2 |
| T73756 | DI0252 | Melanoma | [ICD-11: 2C30] | P29323 | EPHB2 |
| T73756 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P29323 | EPHB2 |
| T73756 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P29323 | EPHB2 |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T28413 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P29320 | EPHA3 |
| T28413 | DI0060 | Brain cancer | [ICD-11: 2A00] | P29320 | EPHA3 |
| T28413 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P29320 | EPHA3 |
| T28413 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P29320 | EPHA3 |
| T97136 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9BUB5 | MKNK1 |
| T97136 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9BUB5 | MKNK1 |
| T97136 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q9BUB5 | MKNK1 |
| T97136 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9BUB5 | MKNK1 |
| T97136 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BUB5 | MKNK1 |
| T12966 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P63316 | TNNC1 |
| T12966 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P63316 | TNNC1 |
| T49989 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P37173 | TGFBR2 |
| T83369 | DI0052 | Bleeding disorder | [ICD-11: GA20-GA21] | P00740 | F9 |
| T83369 | DI0091 | Coagulation defect | [ICD-11: 3B10] | P00740 | F9 |
| T85733 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q02880 | TOP2B |
| T85733 | DI0076 | Chemoprotection | [ICD-11: N.A.] | Q02880 | TOP2B |